Vident Advisory, LLC
- SEC CIK
- 0001744347
- Latest filing
- Aug 12, 2026
SANA holding history
Sana Biotechnology, Inc. in every 13F filed by Vident Advisory, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SANA overviewAll 13F holders of SANAFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −19,645−100.0% | Sold out | Holders |
| Q3 2025 | 19,645 | $69.7K | <0.1% | −17,220−46.7% | Reduced | Holders |
| Q2 2025 | 36,865 | $100.6K | <0.1% | −22,752−38.2% | Reduced | Holders |
| Q1 2025 | 59,617 | $100.2K | <0.1% | +16,326+37.7% | Added | Holders |
| Q4 2024 | 43,291 | $70.6K | <0.1% | +12,861+42.3% | Added | Holders |
| Q3 2024 | 30,430 | $126.6K | <0.1% | +1,491+5.2% | Added | Holders |
| Q2 2024 | 28,939 | $158.0K | <0.1% | +1,880+6.9% | Added | Holders |
| Q1 2024 | 27,059 | $270.6K | <0.1% | +1,889+7.5% | Added | Holders |
| Q4 2023 | 25,170 | $102.7K | <0.1% | +14,924+145.7% | Added | Holders |
| Q3 2023 | 10,246 | $39.7K | <0.1% | – | No prior filing | Holders |